PL210174A1 - - Google Patents

Info

Publication number
PL210174A1
PL210174A1 PL21017478A PL21017478A PL210174A1 PL 210174 A1 PL210174 A1 PL 210174A1 PL 21017478 A PL21017478 A PL 21017478A PL 21017478 A PL21017478 A PL 21017478A PL 210174 A1 PL210174 A1 PL 210174A1
Authority
PL
Poland
Application number
PL21017478A
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10423254&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL210174(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of PL210174A1 publication Critical patent/PL210174A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
PL21017478A 1977-10-11 1978-10-10 PL210174A1 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4219177 1977-10-11

Publications (1)

Publication Number Publication Date
PL210174A1 true PL210174A1 (xx) 1980-08-11

Family

ID=10423254

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21017478A PL210174A1 (xx) 1977-10-11 1978-10-10

Country Status (24)

Country Link
US (2) US4441609A (xx)
JP (1) JPS5476831A (xx)
AU (1) AU525089B2 (xx)
BE (1) BE870988A (xx)
CA (1) CA1105385A (xx)
CH (1) CH642258A5 (xx)
DE (1) DE2843318A1 (xx)
FR (1) FR2405711A1 (xx)
GB (1) GB2005538B (xx)
HK (1) HK73785A (xx)
IE (1) IE47450B1 (xx)
IL (1) IL55660A (xx)
IT (1) IT1109273B (xx)
JO (1) JO984B1 (xx)
KE (1) KE3525A (xx)
MT (1) MTP836B (xx)
MY (1) MY8500996A (xx)
NL (1) NL190631B (xx)
NZ (1) NZ188497A (xx)
PL (1) PL210174A1 (xx)
PT (1) PT68600A (xx)
SE (2) SE435899B (xx)
SG (1) SG34985G (xx)
ZA (1) ZA785682B (xx)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41109B1 (en) * 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus
JPS51101994A (xx) * 1975-02-07 1976-09-08 Glaxo Lab Ltd
DE2964817D1 (en) * 1978-09-06 1983-03-24 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
GR70283B (xx) 1979-10-02 1982-09-03 Beecham Group Ltd
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
US4406887A (en) * 1981-10-13 1983-09-27 Bristol-Myers Company Method for treating resistant bacteria including anaerobes
DE3266580D1 (en) * 1981-12-02 1985-10-31 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
US5743398A (en) * 1984-05-22 1998-04-28 Southpac Trust International, Inc. Floral wrapper utilizing a breathable packaging material
FR2593152B1 (fr) * 1986-01-22 1988-12-23 Adir Conditionnement etanche sous forme de plaquettes alveolaire permettant des echanges gazeux entre les alveoles.
ES2039226T3 (es) * 1986-12-30 1993-09-16 American Cyanamid Company Procedimiento para preparar composiciones que contienen policarbofil.
GB9007143D0 (en) * 1990-03-30 1990-05-30 Beecham Group Plc Veterinary composition
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
GB9009446D0 (en) * 1990-04-26 1990-06-20 Beecham Group Plc Veterinary composition
US5643902A (en) * 1990-04-26 1997-07-01 Pfizer Inc. Veterinary treatment
US5861172A (en) * 1991-05-08 1999-01-19 Laboratorios Beecham Sa Pharmaceutical formulations of compacted granulates of β-lactam antibiotics
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
GB9201639D0 (en) * 1992-01-25 1992-03-11 Smithkline Beecham Plc Pharmaceutical formulations
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9411626D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Package
ES2171192T3 (es) * 1994-08-05 2002-09-01 Smithkline Beecham Plc Recipiente para material sensible a la humedad y metodos correspondientes de desecacion y de reduccion de la descomposicion de productos farmaceuticos.
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
DZ2028A1 (fr) * 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
NZ337247A (en) * 1995-09-07 2001-05-25 Smithkline Beecham Corp Pharmaceutical tablet formulation comprising 875mg amoxycillin
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
ITMI952354A1 (it) * 1995-11-16 1997-05-16 Smithkline Beecham Spa Composizione farmaceutica
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
AT407214B (de) * 1996-03-13 2001-01-25 Biochemie Gmbh Verfahren zur herstellung von hilfsstoffefreien agglomeraten aus beta-lactamantibiotika
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
US6112888A (en) * 1996-06-28 2000-09-05 W. R. Grace & Co.-Conn. Non-reclosable packages containing desiccant matrix
US6180708B1 (en) 1996-06-28 2001-01-30 W. R. Grace & Co.-Conn. Thermoplastic adsorbent compositions containing wax and insulating glass units containing such compositions
GB9616536D0 (en) 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
NZ337043A (en) * 1997-02-14 2001-02-23 Smithkline Beecham Corp Formulation comprising amoxycillin and clavulanate where one layer consists of both compounds and another with only amoxycillin in a single tablet to decrease the size of the tablet without affecting the dosage
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
AU1232500A (en) * 1998-10-30 2000-05-22 Fuisz International Ltd. Improved amoxycillin and clavulanate composition
US6177421B1 (en) 1999-05-04 2001-01-23 Fuisz International Ltd. Amoxicillin and clavulanate composition
IE990159A1 (en) * 1999-02-26 2000-09-20 Fuisz Internat Ltd Storage Stable Amoxycillin and Clavulanate Suspension Composition.
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
AU781218B2 (en) * 1999-08-16 2005-05-12 Revaax Pharmaceuticals, Llc Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of behavioral diseases
US6426342B2 (en) * 1999-08-16 2002-07-30 Revaax Pharmaceuticals, Llc Use of β-lactamase inhibitors as neuroprotectants
SI20411A (sl) * 1999-12-22 2001-06-30 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Vodotopni praški za peroralno raztopino in njihova uporaba
US6905016B2 (en) * 2000-03-14 2005-06-14 Noven Pharmaceuticals, Inc. Packaging system for transdermal drug delivery systems
AT412213B (de) * 2000-05-30 2004-11-25 Sandoz Ag Verfahren zur trocknung von amoxicillin oder amoxicillin-hältigen, oralen, festen pharmazeutischen zusammensetzungen unter verwendung eines gases mit einer definierten gasfeuchte
EP1330236A2 (en) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
JPWO2004016262A1 (ja) * 2002-08-12 2005-12-02 協和醗酵工業株式会社 アミノ酸含有チュアブル錠
US7341742B2 (en) * 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
MY147756A (en) * 2005-05-25 2013-01-15 Theravance Inc Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
DE102006007830A1 (de) * 2006-02-17 2007-08-30 Grünenthal GmbH Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
US9458451B2 (en) 2007-06-21 2016-10-04 Gen-Probe Incorporated Multi-channel optical measurement instrument
AU2008317315A1 (en) * 2007-10-26 2009-04-30 Rexahn Pharmaceuticals, Inc. Pharmaceutical formulation of clavulanic acid
US20100255099A1 (en) * 2007-10-26 2010-10-07 Rexahn Pharmaceuticals, Inc. Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) * 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128135A (en) * 1962-05-29 1964-04-07 Anaconda Wire & Cable Co Moisture-free package
US3567085A (en) * 1968-12-02 1971-03-02 James G Flores Neck-supported pill container
IE41109B1 (en) * 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus

Also Published As

Publication number Publication date
HK73785A (en) 1985-10-04
GB2005538B (en) 1982-05-26
MTP836B (en) 1979-05-11
NZ188497A (en) 1981-05-01
JPS6341886B2 (xx) 1988-08-19
GB2005538A (en) 1979-04-25
FR2405711B1 (xx) 1982-10-29
SG34985G (en) 1985-11-15
IL55660A (en) 1981-09-13
US4441609A (en) 1984-04-10
IT1109273B (it) 1985-12-16
SE435899B (sv) 1984-10-29
SE7810591L (sv) 1979-04-11
CH642258A5 (de) 1984-04-13
CA1105385A (en) 1981-07-21
AU525089B2 (en) 1982-10-21
MY8500996A (en) 1985-12-31
IL55660A0 (en) 1978-12-17
ZA785682B (en) 1979-09-26
JO984B1 (en) 1979-12-01
KE3525A (en) 1985-05-31
AU4050678A (en) 1980-04-17
FR2405711A1 (fr) 1979-05-11
US4301149A (en) 1981-11-17
IE47450B1 (en) 1984-03-21
PT68600A (en) 1978-10-01
NL190631B (nl) 1994-01-03
IT7851415A0 (it) 1978-10-09
JPS5476831A (en) 1979-06-19
SE451668B (sv) 1987-10-26
SE8107592L (sv) 1981-12-17
BE870988A (fr) 1979-04-03
DE2843318A1 (de) 1979-04-12
NL7810176A (nl) 1979-04-17
IE782019L (en) 1979-04-11

Similar Documents

Publication Publication Date Title
DE2828369C3 (xx)
FR2405711B1 (xx)
DE2736874C2 (xx)
FR2376419B1 (xx)
FR2376953B1 (xx)
FR2376383B1 (xx)
FR2376759B1 (xx)
DE2814189C2 (xx)
DK555277A (xx)
DK451577A (xx)
BG25840A1 (xx)
BG25829A1 (xx)
CH597953A5 (xx)
BG25860A1 (xx)
BG25855A1 (xx)
BG25853A1 (xx)
BG25852A1 (xx)
BG25851A1 (xx)
BG25850A1 (xx)
BG25848A1 (xx)
BG25847A1 (xx)
BG25845A1 (xx)
BG25844A1 (xx)
BG25841A1 (xx)
BG25834A1 (xx)